Delisting risk
CDT Equity (CDT)
Develops and out-licenses repurposed clinical assets through solid-form chemistry, computational analysis, and patent creation.
$0.8888
Pre-market−0.03 (−3.17%)
At close$0.9179(−37.98%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions381 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 852.36% | 4.14M shares | |
| Insiders7 holders · as of Sep 2, 2026 | 1,176.66% | 5.72M shares | |
| Strategic holders1 holder · as of May 7, 2025 | 0.01% | 62 shares | |
| Adds to | 2,029.03% |
485.8K company shares as of Aug 26, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (39.08M in the company's Sep 3, 2026 report, 485.8K elsewhere); stakes use the report.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 2,029.03%; nothing is left for Other.
Institutions13F, as of Mar 31, 2026
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 110 | 0.02% | +110new | May 15, 2026 |
| Morgan Stanley | 2 | 0.00% | +2new | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Andrew Reganincl. Algo Holdings, Inc., Corvus Capital Ltd. | 31.56% | 13D/A | Sep 19, 2024 ↗ | |
| Sarborg Ltd | 16.40% | 13G | May 7, 2025 ↗ | |
| Ascent Partners Fund LLC | 9.90% | 13G | Jun 5, 2026 ↗ | |
| A.G.P. / Alliance Global Partners, LLC | 9.80% | 13G | May 15, 2025 ↗ | |
| Limitedincl. Rowland Master Trust | 8.30% | 13G/A | Oct 7, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 28, 2026 | Andrew Regandirector, officer: Chief Executive Officer | Sale | 290 | $0.0001 | 5,692,933 |
| Jun 18, 2026 | Mark Andrew Taylor10 percent owner | Sale · 4 lots | 2,068,000 | $1.42 | 0 |
CongressHouse and Senate disclosures
Not reported.
